Company Filing History:
Years Active: 2022-2025
Title: Kannan Murugan: Innovator in Therapeutic Compounds
Introduction
Kannan Murugan is a notable inventor based in Bengaluru, India. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target critical cellular processes.
Latest Patents
Kannan holds a patent for "Cyclopropyl-amide compounds as dual LSD1/HDAC inhibitors." This patent describes novel compounds that can inhibit both LSD and HDAC, making them useful therapeutic agents for diseases related to cellular growth, such as malignant tumors, schizophrenia, Alzheimer's disease, and Parkinson's disease. The compounds include various forms, such as analogs, stereoisomers, and pharmaceutically acceptable salts.
Career Highlights
Kannan is currently employed at Jubilant Epicore LLC, where he continues to innovate in the field of pharmaceuticals. His work focuses on developing new therapeutic agents that can address complex diseases.
Collaborations
Kannan collaborates with talented professionals in his field, including Sridharan Rajagopal and Mahanandeesha S Hallur. These collaborations enhance the research and development efforts at Jubilant Epicore LLC.
Conclusion
Kannan Murugan's contributions to medicinal chemistry and his innovative patent for dual inhibitors highlight his role as a significant inventor in the pharmaceutical industry. His work has the potential to impact the treatment of various serious diseases.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.